Impact of social and clinical factors on the diagnostic delay of chronic kidney disease: an evaluation study.
Chronic kidney disease
Diagnosis delay
Related factors
Journal
International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
17
03
2021
accepted:
11
10
2021
pubmed:
30
10
2021
medline:
14
6
2022
entrez:
29
10
2021
Statut:
ppublish
Résumé
This study aimed to investigate the impact of social and clinical factors on the diagnostic delay of chronic kidney disease (CKD) among Iranian patients. Our study was conducted on 350 CKD patients who were referred to Faghihi and Motahari clinics (the two largest kidney diseases referral centers in Shiraz the capital of Fars province). Data were collected via an interviewer-administered questionnaire. A multiple linear regression model was used to measure the effect of factors affecting the delay of CKD diagnosis. The medians and Interquartile ranges (IQR) of all delays, patient delay, and doctor delay were 6.5 (0-12.2), 5.1 (0-11.2), and 0.9 (0-3.1) months, respectively. The results showed that women were diagnosed 1.61 months earlier than men (p < 0.05). The duration of all delays in patients residing in the rural areas was 1.28 months longer than patients residing in the urban areas (p < 0.05). Also, patients with perceived good economic status were diagnosed 1.30 months earlier than patients who reported having very poor economic status (p < 0.05). The delay is in part due to the neglect and misinterpretation of symptoms by both patients and physicians. It is necessary to improve the awareness of CKD among general public and medical professionals.
Identifiants
pubmed: 34713367
doi: 10.1007/s11255-021-03037-9
pii: 10.1007/s11255-021-03037-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1603-1612Subventions
Organisme : Shiraz University of Medical Sciences
ID : 99-01-04-22719
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Ghelichi Ghojogh M, Salarilak S, Taghezadeh Afshari A et al (2017) The effect of body mass index on patient and graft survival rate in kidney transplanted patients in Iran. Nephrourol Mon 9(4):1–6. https://doi.org/10.5812/numonthly.14386
doi: 10.5812/numonthly.14386
Kimura K, Hosoya T, Uchida S et al (2018) Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis 72(6):798–810. https://doi.org/10.1053/j.ajkd.2018.06.028
doi: 10.1053/j.ajkd.2018.06.028
pubmed: 30177485
Foster MC, Hwang S-J, Larson MG et al (2008) Overweight, obesity, and the development of stage 3 CKD: the Framingham heart study. Am J Kidney Dis 52(1):39–48. https://doi.org/10.1053/j.ajkd.2008.03.003
doi: 10.1053/j.ajkd.2008.03.003
pubmed: 18440684
pmcid: 2531220
El Nahas AM, Bello AK (2005) Chronic kidney disease: the global challenge. The Lancet 365(9456):331–340. https://doi.org/10.1016/S0140-6736(05)17789-7
doi: 10.1016/S0140-6736(05)17789-7
Marie Patrice H, Joiven N, Hermine F (2019) Factors associated with late presentation of patients with chronic kidney disease in nephrology consultation in Cameroon-a descriptive cross-sectional study. Ren Fail 41(1):384–392. https://doi.org/10.1080/0886022x.2019.1595644
doi: 10.1080/0886022x.2019.1595644
pubmed: 31106687
pmcid: 6534206
Sepanlou SG, Barahimi H, Najafi I et al (2017) Prevalence and determinants of chronic kidney disease in northeast of Iran: results of the Golestan cohort study. PLoS ONE 12(5):e0176540. https://doi.org/10.1371/journal.pone.0176540
doi: 10.1371/journal.pone.0176540
pubmed: 28467510
pmcid: 5414986
Asghari G, Momenan M, Yuzbashian E et al (2018) Dietary pattern and incidence of chronic kidney disease among adults: a population-based study. Nutr Metab (Lond) 15(1):88. https://doi.org/10.1186/s12986-018-0322-7
doi: 10.1186/s12986-018-0322-7
Hill NR, Fatoba ST, Oke JL et al (2016) Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS One 11(7):e0158765. https://doi.org/10.1371/journal.pone.0158765
doi: 10.1371/journal.pone.0158765
pubmed: 27383068
pmcid: 4934905
Moazzeni SS, Arani RH, Hasheminia M et al (2021) High incidence of chronic kidney disease among Iranian diabetic adults: using CKD-EPI and MDRD equations for estimated glomerular filtration rate. Diabetes Metab J. https://doi.org/10.4093/dmj.2020.0109
doi: 10.4093/dmj.2020.0109
pubmed: 33715338
pmcid: 8497933
Sud M, Tangri N, Levin A et al (2014) CKD stage at nephrology referral and factors influencing the risks of ESRD and death. Am J Kidney Dis 63(6):928–936. https://doi.org/10.1053/j.ajkd.2013.12.008
doi: 10.1053/j.ajkd.2013.12.008
pubmed: 24485146
Dianatinasab M, Fararouei M, Mohammadianpanah M et al (2016) Impact of social and clinical factors on diagnostic delay of breast cancer: a cross-sectional Study. Medicine (Baltimore). https://doi.org/10.1097/md.0000000000004704
doi: 10.1097/md.0000000000004704
Kazerooni P, Fararouei M, Nejat M et al (2018) Under-ascertainment, under-reporting and timeliness of Iranian communicable disease surveillance system for zoonotic diseases. Public Health 154:130–135. https://doi.org/10.1016/j.puhe.2017.10.029
doi: 10.1016/j.puhe.2017.10.029
pubmed: 29241098
Mobasheri F, Jaberi AR, Hasanzadeh J et al (2020) Multiple sclerosis diagnosis delay and its associated factors among Iranian patients. Clin Neurol Neurosurg 199:106278. https://doi.org/10.1016/j.clineuro.2020.106278
doi: 10.1016/j.clineuro.2020.106278
pubmed: 33069931
Bah AO, Lamine C, Balde MC et al (2015) Epidemiology of chronic kidney diseases in the Republic of Guinea; future dialysis needs. J Nephropathol 4(4):127–133. https://doi.org/10.12860/jnp.2015.24
doi: 10.12860/jnp.2015.24
pubmed: 26457260
pmcid: 4596297
Yao KH, Guehi MC, Konan SD et al (2018) Prevalence and risk factors for chronic kidney disease in general population of Yopougon (Côte d’ivoire); a cross-sectional study. J Renal Inj Prev 7(1):27–32. https://doi.org/10.15171/jrip.2018.06
doi: 10.15171/jrip.2018.06
Inker LA, Astor BC, Fox CH et al (2014) 2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735. https://doi.org/10.1053/j.ajkd.2014.01.416
doi: 10.1053/j.ajkd.2014.01.416
pubmed: 24647050
Levin A, Stevens PE, Bilous RW et al (2013) Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150. https://doi.org/10.1038/kisup.2012.73
doi: 10.1038/kisup.2012.73
Vassalotti JA, Centor R, Turner BJ et al (2016) Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med 129(2):153-162.e7. https://doi.org/10.1016/j.amjmed.2015.08.025
doi: 10.1016/j.amjmed.2015.08.025
pubmed: 26391748
Bakris GL, Weir MR, Shanifar S et al (2003) Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 163(13):1555–1565. https://doi.org/10.1001/archinte.163.13.1555
doi: 10.1001/archinte.163.13.1555
pubmed: 12860578
Zoungas S, Chalmers J, Neal B et al (2014) Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 371(15):1392–1406. https://doi.org/10.1056/nejmoa1407963
doi: 10.1056/nejmoa1407963
pubmed: 25234206
Hoerger TJ, Wittenborn JS, Segel JE et al (2010) A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis 55(3):463–473. https://doi.org/10.1053/j.ajkd.2009.11.017
doi: 10.1053/j.ajkd.2009.11.017
pubmed: 20116910
Moyer VA (2012) Screening for chronic kidney disease: US preventive services task force recommendation statement. Ann Intern Med 157(8):567–570. https://doi.org/10.7326/0003-4819-157-8-201210160-00533
doi: 10.7326/0003-4819-157-8-201210160-00533
pubmed: 22928170
Qaseem A, Hopkins RH Jr, Sweet DE et al (2013) Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American college of physicians. Ann Intern Med 159(12):835–847. https://doi.org/10.7326/0003-4819-159-12-201312170-00726
doi: 10.7326/0003-4819-159-12-201312170-00726
pubmed: 24145991
Mahajan C, Tiwari V, Divyaveer SS et al (2020) Spectrum of renal biopsies; three-year data from a tertiary care centre of eastern India. J Nephropharmacol 9(2):e20. https://doi.org/10.15171/npj.2020.20
doi: 10.15171/npj.2020.20
Sprangers B, Evenepoel P, Vanrenterghem Y (2006) Late referral of patients with chronic kidney disease: no time to waste. Mayo Clin Proc 81(11):1487–1494. https://doi.org/10.4065/81.11.1487
doi: 10.4065/81.11.1487
pubmed: 17120405
Lee J, Lee JP, An JN et al (2016) Factors affecting the referral time to nephrologists in patients with chronic kidney disease: a prospective cohort study in Korea. Medicine (Baltimore) 95(19):e3648. https://doi.org/10.1097/md.0000000000003648
doi: 10.1097/md.0000000000003648
Smart NA, Titus TT (2011) Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med 124(11):1073–108. e2. https://doi.org/10.1016/j.amjmed.2011.04.026
doi: 10.1016/j.amjmed.2011.04.026
pubmed: 22017785
Ghojogh MG, Salarilak S, Afshari AT (2018) Impact of type of donor on graft and patient survival rate in kidney transplanted patients in Iran. J Renal Inj Prev 7(4):264–268. https://doi.org/10.15171/jrip.2018.59
doi: 10.15171/jrip.2018.59
Parad MT, Fararouei M, Mirahmadizadeh AR et al (2021) Thyroid cancer and its associated factors: a population-based case-control study. Int J Cancer 149(2):254–260. https://doi.org/10.1002/ijc.33537
doi: 10.1002/ijc.33537
Sedaghat Z, Zibaeenejad M, Fararouei M (2019) Hypertension, risk factors and coronary artery stenosis: a case-control study. Clin Exp Hypertens 41(2):181–186. https://doi.org/10.1080/10641963.2018.1462376
doi: 10.1080/10641963.2018.1462376
Levey AS, Andreoli SP, DuBose T et al (2007) Chronic kidney disease: common, harmful and treatable–World Kidney Day 2007. Am J Nephrol 27(1):108–112. https://doi.org/10.1159/000099801
doi: 10.1159/000099801
pubmed: 17308371
Kazerooni P, Nejat M, Akbarpoor M et al (2019) Underascertainment, underreporting, representativeness and timeliness of the Iranian communicable disease surveillance system for tuberculosis. Public Health 171:50–56. https://doi.org/10.1016/j.puhe.2019.03.008
doi: 10.1016/j.puhe.2019.03.008
pubmed: 31100694
Stanifer JW, Patel UD, Karia F et al (2015) The determinants of traditional medicine use in northern Tanzania: a mixed-methods study. PLoS ONE 10(4):e0122638. https://doi.org/10.1371/journal.pone.0122638
doi: 10.1371/journal.pone.0122638
pubmed: 25848762
pmcid: 4388565
Halle MP, Jimkap NN, Kaze FF et al (2017) Cost of care for patients on maintenance haemodialysis in public facilities in Cameroon. Afr J Nephrol 20(1):230–237. https://doi.org/10.21804/20-1-2548
doi: 10.21804/20-1-2548
Khan I, Catto G, Edward N et al (1994) Chronic renal failure: factors influencing nephrology referral. QJM An Int J Med 87(9):559–564. https://doi.org/10.1093/oxfordjournals.qjmed.a068968
doi: 10.1093/oxfordjournals.qjmed.a068968
Hood SA, Sondheimer JH (1998) Impact of pre-ESRD management on dialysis outcomes: a review. Semin Dial 11(3):175–180. https://doi.org/10.1111/j.1525-139X.1998.tb00329.x
doi: 10.1111/j.1525-139X.1998.tb00329.x
Huisman RM (2004) The deadly risk of late referral. Nephrol Dial Transplant 19(9):2175–2180. https://doi.org/10.1093/ndt/gfh409
doi: 10.1093/ndt/gfh409
pubmed: 15299096
Kiadaliri AA, Najafi B, Haghparast-Bidgoli H (2011) Geographic distribution of need and access to health care in rural population: an ecological study in Iran. Int J Equity Health 10(1):1–7. https://doi.org/10.1186/1475-9276-10-39
doi: 10.1186/1475-9276-10-39
Mobaraki H, Hassani A, Kashkalani T et al (2013) Equality in distribution of human resources: the case of Iran’s Ministry of Health and Medical Education. Iran J Public Health 42(Supple1):161–165 (PMID: 23865035; PMCID: PMC3712591)
pubmed: 23865035
pmcid: 3712591
Babu GR, Samari G, Cohen SP et al (2011) Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev 12(7):1647–1655 (PMID: 22126539)
pubmed: 22126539
Partridge AH, Hughes ME, Ottesen RA et al (2012) The effect of age on delay in diagnosis and stage of breast cancer. Oncologist 17(6):775–782. https://doi.org/10.1634/theoncologist.2011-0469
doi: 10.1634/theoncologist.2011-0469
pubmed: 22554997
pmcid: 3380876
Kingwell E, Leung AL, Roger E et al (2010) Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts. J Neurol Sci 292(1–2):57–62. https://doi.org/10.1016/j.jns.2010.02.007
doi: 10.1016/j.jns.2010.02.007
pubmed: 20202651
Neal R, Allgar V (2005) Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the ‘National Survey of NHS Patients: Cancer.’ Br J Cancer 92(11):1971–1975. https://doi.org/10.1038/sj.bjc.6602623
doi: 10.1038/sj.bjc.6602623
pubmed: 15900296
pmcid: 2361785
Dhatariya K, James J, Kong MF et al (2020) Diabetes at the front door. A guideline for dealing with glucose related emergencies at the time of acute hospital admission from the Joint British Diabetes Society (JBDS) for Inpatient Care Group. Diabet Med 37(9):1578–1589. https://doi.org/10.1111/dme.14304
doi: 10.1111/dme.14304
pubmed: 32279343
Fabi A, Bhargava R, Fatigoni S et al (2020) Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol 31(6):713–723. https://doi.org/10.1016/j.annonc.2020.02.016
doi: 10.1016/j.annonc.2020.02.016
pubmed: 32173483
Glaspy JA, Lim-Watson MZ, Libre MA et al (2020) Hypophosphatemia associated with intravenous iron therapies for iron deficiency anemia: a systematic literature review. Ther Clin Risk Manag 16:245–259. https://doi.org/10.2147/tcrm.s243462
doi: 10.2147/tcrm.s243462
pubmed: 32308402
pmcid: 7152545
Zafari N, Asgari S, Lotfaliany M et al (2017) Impact of hypertension versus diabetes on cardiovascular and all-cause mortality in Iranian older adults: results of 14 years of follow-up. Sci Rep 7(1):14220. https://doi.org/10.1038/s41598-017-14631-2
doi: 10.1038/s41598-017-14631-2
pubmed: 29079827
pmcid: 5660198
Montazeri A, Ebrahimi M, Mehrdad N et al (2003) Delayed presentation in breast cancer: a study in Iranian women. BMC Womens Health 3(1):1–6. https://doi.org/10.1186/1472-6874-3-4
doi: 10.1186/1472-6874-3-4